» Articles » PMID: 33884014

Serum Tyrosine Level in Acute Murine Toxoplasmosis

Overview
Specialty Parasitology
Date 2021 Apr 22
PMID 33884014
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Toxoplasmosis is a zoonotic disease caused by the obligate intracellular parasite, . This global infectious disease has been associated with behavioral changes in rodents and can result in humans' neuropsychiatric symptoms. Since the neurotransmitters alteration can cause a behavioral change, in this study, tyrosine level, as a precursor of dopamine, was evaluated in acute murine toxoplasmosis during 2015 and 2016 in Shiraz, Iran.

Methods: At the first, 10 tachyzoites of were subcutaneously inoculated to 50 BALB/c mice as experimental groups and 10 mice inoculated by PBS considered as the control group. After that, daily, one group of mice was bled, and sera were collected. Then, their serum tyrosine level was evaluated by HPLC method.

Results: After data analysis, the maximum mean serum tyrosine level was seen at 2 day of post parasite inoculation (0.0194 mg/ ml), with a significant difference compared to the control group (0.0117 mg/ ml, =0.025). Moreover, the least quantity of serum tyrosine (0.076 mg/ml) was seen on the 5 day, after parasite inoculation, however, no significant difference was seen.

Conclusion: Serum tyrosine level increased in 2 d after inoculation of , but the level regularly decreased in successive days. Tyrosine level increased by phenylalanine hydroxylase 2 days after inoculation, then tyrosine decreased by tyrosine hydroxylase in the next days. tyrosine hydroxylase enzymes, at primary days of toxoplasmosis, effect on tyrosine production, and after that, the most effect on tyrosine consumption.

Citing Articles

Acute toxoplasmosis can increase serum dopamine level.

Omidian M, Asgari Q, Bahreini M, Moshki S, Sedaghat B, Adnani Sadati S J Parasit Dis. 2022; 46(2):337-342.

PMID: 35692467 PMC: 9177907. DOI: 10.1007/s12639-021-01447-1.

References
1.
Alipour A, Shojaee S, Mohebali M, Tehranidoost M, Abdi Masoleh F, Keshavarz H . Toxoplasma infection in schizophrenia patients: a comparative study with control group. Iran J Parasitol. 2012; 6(2):31-7. PMC: 3279881. View

2.
Babaie J, Sayyah M, Fard-Esfahani P, Golkar M, Gharagozli K . Contribution of dopamine neurotransmission in proconvulsant effect of Toxoplasma gondii infection in male mice. J Neurosci Res. 2017; 95(10):1894-1905. DOI: 10.1002/jnr.24036. View

3.
Torres L, Robinson S, Kim D, Yan A, Cleland T, Bynoe M . Toxoplasma gondii alters NMDAR signaling and induces signs of Alzheimer's disease in wild-type, C57BL/6 mice. J Neuroinflammation. 2018; 15(1):57. PMC: 5824585. DOI: 10.1186/s12974-018-1086-8. View

4.
Asgari Q, Keshavarz H, Shojaee S, Motazedian M, Mohebali M, Miri R . In Vitro and In Vivo Potential of RH Strain of Toxoplasma gondii (Type I) in Tissue Cyst Forming. Iran J Parasitol. 2014; 8(3):367-75. PMC: 3887236. View

5.
Armando I, Jezova M, Bregonzio C, Baiardi G, Saavedra J . Angiotensin II AT1 and AT2 receptor types regulate basal and stress-induced adrenomedullary catecholamine production through transcriptional regulation of tyrosine hydroxylase. Ann N Y Acad Sci. 2004; 1018:302-9. DOI: 10.1196/annals.1296.036. View